1. Home
  2. CKX vs SABS Comparison

CKX vs SABS Comparison

Compare CKX & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKX
  • SABS
  • Stock Information
  • Founded
  • CKX 1930
  • SABS 2014
  • Country
  • CKX United States
  • SABS United States
  • Employees
  • CKX N/A
  • SABS N/A
  • Industry
  • CKX Oil & Gas Production
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CKX Energy
  • SABS Health Care
  • Exchange
  • CKX Nasdaq
  • SABS Nasdaq
  • Market Cap
  • CKX 26.4M
  • SABS 23.9M
  • IPO Year
  • CKX 1998
  • SABS N/A
  • Fundamental
  • Price
  • CKX $12.80
  • SABS $3.70
  • Analyst Decision
  • CKX
  • SABS Strong Buy
  • Analyst Count
  • CKX 0
  • SABS 5
  • Target Price
  • CKX N/A
  • SABS $12.40
  • AVG Volume (30 Days)
  • CKX 953.0
  • SABS 78.4K
  • Earning Date
  • CKX 01-01-0001
  • SABS 11-06-2024
  • Dividend Yield
  • CKX N/A
  • SABS N/A
  • EPS Growth
  • CKX N/A
  • SABS N/A
  • EPS
  • CKX 0.22
  • SABS N/A
  • Revenue
  • CKX $2,030,981.00
  • SABS $1,512,723.00
  • Revenue This Year
  • CKX N/A
  • SABS N/A
  • Revenue Next Year
  • CKX N/A
  • SABS N/A
  • P/E Ratio
  • CKX $56.93
  • SABS N/A
  • Revenue Growth
  • CKX 88.35
  • SABS N/A
  • 52 Week Low
  • CKX $12.21
  • SABS $2.16
  • 52 Week High
  • CKX $14.44
  • SABS $9.72
  • Technical
  • Relative Strength Index (RSI)
  • CKX 35.73
  • SABS 57.82
  • Support Level
  • CKX $12.63
  • SABS $3.17
  • Resistance Level
  • CKX $13.01
  • SABS $4.37
  • Average True Range (ATR)
  • CKX 0.15
  • SABS 0.45
  • MACD
  • CKX -0.02
  • SABS -0.01
  • Stochastic Oscillator
  • CKX 19.77
  • SABS 59.83

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership in the form of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: